- 1Faculty of Psychology, Kazimierz Wielki University, Bydgoszcz, Poland
- 2Faculty of Health Sciences, School of Population Health, Curtin University, Perth, WA, Australia
- 3School of Psychological Science, The University of Western Australia, Perth, WA, Australia
- 4Brain and Behaviour Division, Telethon Kids Institute, Perth, WA, Australia
The Perth Alexithymia Questionnaire (PAQ) is a 24-item self-report measure of alexithymia. Originally developed in English, it was designed to try to enable more comprehensive (i.e., facet-level and valence-specific) alexithymia assessments. This study aimed to introduce and validate a Polish version of the PAQ. Our sample were 1,008 people (69.44% females, 30.06% males and 0.50% non-binary) aged 18–78 (M = 29.69, SD = 14.15) from the general community. The PAQ's factor structure was verified with confirmatory factor analysis, and convergent and divergent validity were assessed via relationships with other measures of alexithymia and mental health symptoms. Our results indicated strong factorial validity, conforming to the intended subscale structure. As expected, all PAQ subscales correlated in expected directions with another established alexithymia measure, and markers of depression, anxiety, and stress symptoms. The PAQ showed good discriminant validity in terms of measuring an alexithymia construct that was separable from people's current level of distress. Test-retest and internal consistency reliabilities were also good. Overall, the Polish PAQ therefore appears to have strong psychometric properties. Our findings add to a growing body of literature supporting the validity of the PAQ, and the multidimensional nature of the alexithymia construct, across different nations and languages.
Introduction
The term alexithymia, meaning “no words for emotions” in Greek, was first coined by Nemiah and Sifneos (1) based on their observations of psychiatric patients with psychosomatic disorders. Alexithymia is a multidimensional trait with three core components: difficulty identifying one's own feelings (DIF), difficulty describing feelings (DDF), and externally orientated thinking (EOT; expressed in terms of one rarely focusing on their internal emotional states (2, 3). Alexithymia is established as a transdiagnostic risk factor for a range of psychopathologies, including psychosomatic disorders and affective disorders (4). Indeed, the clinical importance of alexithymia assessment has been emphasized in the recent Diagnostic Criteria for Psychosomatic Research (5), and scholars have long noted that alexithymia can impair the effectiveness of psychotherapy approaches (6). Much of this link between alexithymia and psychopathology appears to be due to the impairing effect that alexithymia has on emotion regulation, whereby people with alexithymia have more difficulty effectively managing their emotional states (4, 7).
The assessment of alexithymia is therefore important. Traditionally, alexithymia has been most commonly assessed using Bagby et al. (8) 20-item Toronto Alexithymia Scale-20 (TAS-20). However, the TAS-20 was not originally designed to assess alexithymia at the facet (i.e., DIF, DDF, EOT) level, and the TAS-20 developers recommend that people use only the total scale score as an overall marker of alexithymia (9), with others noting low reliability in the TAS-20 EOT items if an EOT subscale is extracted (10). Increasingly, researchers and clinicians are interested in examining alexithymia at the facet level (11), a trend that has emphasized the need for more comprehensive assessment tools. Moreover, assessment tools for other emotional constructs are increasingly beginning consider valence in their assessment [i.e., assessing constructs across both negative and positive emotions; see Becerra et al. (12)], and recent data has indicated that people typically report higher levels of alexithymia for negative emotions compared to positive emotions (13).
The Perth Alexithymia Questionnaire (PAQ) was recently introduced to try to enable more comprehensive and valence specific alexithymia assessments (14). Our aim in this study is to introduce and validate a Polish version of the PAQ.
The PAQ is a 24-item self-report measure designed to assess the DIF, DDF and EOT components of alexithymia. A key feature of the PAQ is that valence-specific DIF and DDF subscales can be extracted (i.e., exploring these facets across positive and negative emotions separately). Thus, the PAQ consists of five intended subscales: (1) Negative-Difficulty identifying feelings (N-DIF; 4 items, e.g., When I'm feeling bad, I get confused about what emotion it is), (2) Positive-Difficulty identifying feelings (P-DIF; 4 items, e.g., When I'm feeling good, I can't tell whether I'm happy, excited, or amused), (3) Negative-Difficulty describing feelings (N-DDF; 4 items, e.g., When I'm feeling bad, I can't talk about those feelings in much depth or detail), (4) Positive-Difficulty describing feelings (P-DDF; 4 items, e.g., When I'm feeling good, if I try to describe how I'm feeling I don't know what to say) and (5) General-Externally orientated thinking (G-EOT; 8 items, e.g., I don't pay attention to my emotions). These five subscales can also be combined into several composite scores, including a total scale score assessing overall alexithymia.
Originally developed in English, several language translations of the PAQ have now been published, including Turkish (15), Iranian (16, 17), and Spanish (18) versions. Factor analyses across language versions have consistently supported a 5-factor structure, conforming to the intended five factors (13, 19, 20). The superiority of this five-factor model, in comparison to simpler models, has therefore supported the value of considering facet-level and valence-specific components in alexithymia assessments. All subscales and the total scale score have also consistently shown high levels of internal consistency reliability (21), though test-retest reliability has not yet been evaluated in a published study.
Comparisons with other measures of alexithymia, emotion regulation difficulties, or psychopathology symptoms have also supported the clinical relevance of PAQ scores. The PAQ correlates highly with the TAS-20, although current evidence from direct comparisons suggest that the TAS-20 appears to assess alexithymia only for negative emotions (20, 21). High levels of alexithymia, as assessed by the PAQ are also associated with more emotion regulation difficulties, and higher levels of psychopathology, as would be expected (14). Crucially, the PAQ also appears to assess a construct that is statistically separable from people's current levels of distress (i.e., discriminant validity). In contrast, amidst concerns that alexithymia measures might actually assess distress levels, some discriminant validity problems have been identified in the TAS-20 (22–24).
Whilst psychometric results with the PAQ have been promising to date, as a recently introduced measure, there is a need to continue evaluating its performance in different settings. There is also presently no Polish version of the PAQ, thus limiting capacity to use it with Polish-speaking populations. The aim of the present study was therefore to introduce a Polish version of the PAQ and to evaluate its psychometric properties (i.e., factor structure, internal consistency reliability, test-retest reliability, convergent and divergent validity). We were also interested in presenting general community group norms to help facilitate the interpretation of PAQ scores, and in evaluating the extent to which PAQ scores might differ across demographic categories.
Based on the theory and past work, we anticipated that the 5-factor structure would be the best factor structure, that the PAQ would correlate highly with another alexithymia measure (the TAS-20), as well as measures of depression, anxiety, and stress symptoms. Based on past findings with the TAS-20 (25), we also anticipated that males may report a higher level of alexithymia on the PAQ than females, and that alexithymia levels would increase with age.
Materials and methods
Participants and procedure
The sample consisted of 1,008 Polish-speaking adults (700 females, 303 males and 5 non-binary) with ages ranging from 18 to 78 (M = 29.69, SD = 14.15) from the general population. Detailed sociodemographic characteristics of the sample are presented in Table 1.
The participants were recruited in the first half of 2022 via social networks Facebook and Instagram where there was a link to an online anonymous survey. The Kazimierz Wielki University Scientific Research Ethics Committee approved the study. All respondents provided their informed consent digitally before they answered the questions. Not all respondents completed all the measures to avoid common method bias and stress during filling out the questionnaires.
Measures
1. The PAQ is a 24-item self-report measure of alexithymia (14). The PAQ consists of five subscales (N-DIF, P-DIF, N-DDF, P-DDF, G-EOT) and several composite scores, including a total scale score. Items are scored on a 7-point scale ranging from 1 (strongly disagree) to 7 (strongly agree). Higher scores indicate higher levels of alexithymic traits.
2. The TAS-20 is a 20-item self-report measure of alexithymia (8). The Polish version of the questionnaire was used (26). The TAS-20 was originally designed to provide only a total scale score, but DIF (seven items, e.g., I am often confused about what emotion I am feeling), DDF (five items, e.g., I am able to describe my feelings easily), and EOT (eight items, e.g., I prefer to analyse problems rather than just describe them) subscales are also derived. Items are scored on a 5-point scale ranging from 1 (strongly disagree) to 5 (strongly agree). There are five reverse-scored items. Higher scores indicate higher levels of alexithymia.
3. The Patient Health Questionnaire-4 (PHQ-4) developed by Kroenke et al. (27) in its Polish version by Larionow and Mudło-Głagolska (28) is a 4-item questionnaire for measuring anxiety and depressive symptoms in the previous 2 weeks. The PHQ-4 has two subscales: anxiety (two items, e.g., Feeling nervous, anxious or on edge) and depression (two items, e.g., Feeling down, depressed, or hopeless). The overall score of anxiety-depressive symptoms can be calculated. The PHQ-4 uses a 4-point Likert scale from 0 (not at all) to 3 (nearly every day). Higher scores indicate higher levels of symptoms.
4. The Perceived Stress Scale-4 (PSS-4), developed by Cohen et al. (29) in its Polish version (30), was used for measuring the level of perceived stress during the previous month. The PSS-4 has four items (e.g., In the last month, how often have you felt that you were unable to control the important things in your life?), which are due to be evaluated on a 4-point Likert scale from 0 (never) to 4 (very often). Two items are reverse-scored. Higher score indicates a higher level of perceived stress.
Analytic strategy
The data were screened for accuracy (minimum and maximum range of each variable). There were no missing data. Statistical analysis was carried out using Statistica (version 13.3), IBM SPSS Statistics (version 28) and R (version 4.2.1). In R the following packages were used: lavaan and semTools (for confirmatory factor analysis [CFA]), as well as EFAtools and psych (for exploratory factor analysis [EFA] and reliability analysis).
Translation of the questionnaire
The original English version of the PAQ was translated into Polish by three independent translators (fluent in both Polish and English) and a common Polish translation of the questionnaire was developed. Then it was translated back into English, and this back translation was compared with the original version of the PAQ. Minor corrections were made, resulting in the final Polish version administered in this study.
Age and gender differences
Pearson correlations between PAQ scores and age were calculated. Additionally, a series of one-way analyses of covariance (ANCOVAs) were used to investigate the influence of gender and age on PAQ scores.
Factor structure
The following theoretically informed models were tested: (1) a 1-factor model (all 24 items were specified to load on a “general alexithymia” factor), (2) a 2-factor correlated model comprised of two first-order factors (G-EOT and G-DAF) distinguishing between the attention and appraisal components of alexithymia, (3) a 3-factor correlated model comprised of three first-order factors (G-DIF, G-DDF and G-EOT) corresponding to the 3 facets of alexithymia but not accounting for valence, (4) a 3-factor correlated valence-specific model with three first-order factors (N-DAF, P-DAF and G-EOT) where no distinction was made between the identifying and describing components of appraisal but valence was accounted for, and (5) a 5-factor correlated model that reflected the intended subscale structure of the PAQ (N-DIF, P-DIF, N-DDF, P-DDF and G-EOT as five first-order factors).
A sample size of more than 1,000 participants is generally regarded as excellent for factor analytic studies (31), thus our sample size was appropriate for examination of the 24-item PAQ. CFA with maximum likelihood estimation with robust standard errors and the Satorra-Bentler scaled test statistic was used. Fit was judged based on the following fit index values: root mean square error of approximation (RMSEA), standardized root mean square residual (SRMR), comparative fit index (CFI), and Tucker–Lewis index (TLI). RMSEA and SRMR values below 0.08, and CFI and TLI values greater than 0.9 indicate acceptable fit (32). The factor models were also directly compared using the Akaike Information Criterion (AIC). Lower AIC value indicates better fit (33).
Internal consistency reliability
Cronbach's alpha coefficients (α) and McDonald's omega values (ω) with 95% confidence intervals were calculated for all PAQ subscales and the total score.
Test-retest reliability
Intraclass correlation coefficients (ICCs; two-way mixed method with absolute agreement type) were calculated to assess the correlation between PAQ scores at baseline and 1-month follow-up. Paired samples t-tests (two-sided p) were used to compare PAQ scores between these two time points. The standard error of measurement (SEM) and the minimum detectable change (MDC), with a 95% confidence interval, were calculated. The MDC represents the minimum change that a person must present on questionnaire results to ensure that the observed change is real and is not due to a measurement error (34).
Convergent and divergent validity
Pearson correlations between PAQ scores and TAS-20, PHQ-4, and PSS-4 scores were examined to assess convergent and divergent validity. Additionally, discriminant validity was evaluated by conducting a second-order exploratory factor analysis (principal axis factoring with direct oblimin rotation) of the five PAQ subscales, the two PHQ-4 subscales and the PSS-4 score. It was expected that the PAQ subscales would load on an alexithymia factor, and the PHQ-4 and PSS-4 subscales on a separate negative affect factor (thus supporting discriminant validity).
Group norms
Group norms were calculated using the sten scale and based on the data of the whole sample. Sten scores were calculated from Z-scores using the formula: sten = (Z-score × 2) + 5.5 (35).
Results
Table 2 presents descriptive statistics for all the variables in the study. Skewness scores for the PAQ subscales ranged from 0.24 to 0.90, whereas kurtosis ranged from −1.28 to −0.11 (refer to Supplementary Table 1), indicating the distribution of subscales scores was normal. Age, PHQ-4, PSS-4 and TAS-20 scores were also normally distributed (skewness values ranged from −0.15 to 1.31, and kurtosis ones from −1.22 to 1).
Table 2. Descriptive statistics and Cronbach's alpha (α) and McDonald's omega values (ω) with 95% confidence intervals (CI) for the PAQ, PHQ-4, PSS-4 and TAS-20.
We conducted a paired t-test to compare N-DAF and P-DAF scores in order to examine whether emotion valence (negative or positive) influenced the extent of people's difficulties appraising their emotions. The participants reported significantly more difficulties appraising their negative emotions compared to their positive emotions, t(1007) = 14.478, p < 0.001, Cohen's d = 0.456.
Age and gender differences
A series of one-way ANCOVAs were conducted to examine whether males and females, and younger and older people differed with respect to the PAQ results (N-DIF, P-DIF, N-DDF, P-DDF, G-EOT, and total PAQ score). Gender was used as the independent variable and entered as age as a covariate. Compared to males, and adjusting for age, females scored significantly higher on N-DIF [F(1,1000) = 15.664, p < 0.001, partial η2 = 0.015] and N-DDF [F(1,1000) = 7.898, p = 0.005, partial η2 = 0.008]. Females' and males' PAQ scores were not significantly different for the P-DIF, P-DDF, G-EOT subscales and the total scale score (p > 0.05). Age was a significant covariate for all of these analyses (p < 0.001), suggesting that levels of alexithymic traits did differ between younger and older adults. Alexithymic traits were negatively correlated with age (r from −0.20 to −0.33, all p < 0.001; refer to Supplementary Table 2), indicating that younger adults were significantly more alexithymia than older adults.
CFA
As expected, the 1-factor, 2-factor and 3-factor (no valence) models were a poor fit to the data (Table 3). The 3-factor (valence) model was a good fit, and the 5-factor model was also a good fit with the best fit index values overall. However, in the 5-factor model analysis, the covariance matrix of latent variables was not positive definite. This is a common situation/issue in CFAs called a Heywood case (36). Subsequently, we analyzed the modification indices, which indicated the need to add three correlated error terms into the 5-factor model. Bollen and Lennox (37) noted that errors are generally independent of one another, although they are possible among items using similar wordings or appearing near to each other on the questionnaire. Based on the modification indices, we added error terms between items 1 and 2, and between items 1 and 4, and between items 4 and 5. We felt adding these error terms was theoretically justifiable because of conceptual and wording similarities between those items, and their addition improved fit index values further. All item factor loadings were strong for the 5-factor model with the three error term correlations added (loadings ≥ 0.67, all p < 0.001; refer to Supplementary Table 1).
Table 3. Goodness-of-fit indices for the PAQ models (maximum likelihood estimation with robust standard errors and a Satorra-Bentler scaled test statistic; N = 1008).
The values of estimated correlations between the subscale factors of the 5-factor model with three error term correlations added are shown in Table 4. The estimated correlations between subscales of N-DIF and N-DDF were positive and high (r = 0.94, p < 0.001), as well as between subscales of P-DIF and P-DDF (r = 0.95, p < 0.001). Slightly lower correlations were reported between G-EOT and N-DIF, N-DDF, P-DIF as well as P-DDF, which ranged from 0.63 to 0.70 (all p < 0.001). Summarizing, the CFA results showed that 3-factor (valence) and 5-factor model with three error terms are optimal solutions, with the 5-factor model being superior in fit statistics. Thus, we selected the 5-factor model with three error terms as the best solution in our data-set, reflecting the intended factor structure of the questionnaire.
Table 4. Estimated correlations between the factors (subscales) of the 5-factor PAQ model (all p < 0.001).
Convergent and divergent validity
The relationships between the PAQ scores and other study variables were analyzed (see Supplementary Table 2). In general, the PAQ subscales and total score were significantly highly positively correlated with the other measure of alexithymia (overall TAS-20 score; r from 0.60 to 0.78, all p < 0.001), stress (r from 0.20 to 0.42, all p < 0.001), as well as anxiety (r from 0.16 to 0.40, all p < 0.001) and depressive symptoms (r from 0.25 to 0.40, all p < 0.001).
Our second-order EFA of the alexithymia subscales (the five PAQ subscales), stress (the PSS-4 score), anxiety, and depressive symptoms (the two PHQ-4 subscales) extracted two factors (i.e., factor 1 “general alexithymia” and factor 2 “stress, anxiety and depressive symptoms”; refer Supplementary Table 3). All the PAQ subscales loaded cleanly on the “general alexithymia factor” (loadings from 0.742 to 0.899) and did not load on the “stress, anxiety and depressive symptoms” factor (loadings from −0.089 to 0.138). Thus, the alexithymia construct, as measured by the PAQ, was statistically separable from one's current level of negative affect.
Internal consistency reliability
All PAQ subscales/composite scores and the total score showed good internal consistency reliability (α ≥ 0.87 and ω ≥ 0.86).
Test-retest reliability
Twenty two participants (19 females and 3 males, aged 20–41 (M = 23.64, SD = 5.51) filled out the PAQ two times with approximately 1 months' interval between each test. ICCs of all the PAQ scores between the two time measurements were high (≥ 0.85) and statistically significant (all p < 0.001; refer to Supplementary Table 4). The paired samples t-test revealed statistically significant differences on N-DIF, N-DDF, G-EOT, and the total PAQ score between the two time points (score decrease at second time point). However, the differences were lower than MDC, thus these changes cannot be considered meaningful or clinically important, thus supporting the PAQ's test-retest reliability.
Group norms
Based on the current study data, group norms for PAQ scores were calculated using the sten scale for females and males in two age groups (aged 18–29 and ≥ 30; see Supplementary Tables 5–8). Detailed sociodemographic characteristics of these study samples are presented in Table 1.
Discussion
The aim of the study was to introduce a Polish version of the PAQ and explore its psychometric properties. Overall, the analyses empirically supported the validity and reliability of the Polish version of the PAQ as a measure of alexithymia. The 5-factor model, corresponding to the PAQ's intended subscale structure, had the best fit to the data. Within each valence domain, N-DIF and N-DDF, as well as P-DIF and P-DDF, were highly correlated with each other, however there was statistical value in separating them. The obtained results are thus in line with the conclusions presented in other validation studies (15–17) regarding the predominance of the intended 5-factor model over other factor solutions. The internal consistency reliability of all five subscales and the total score was high, and test-retest reliability was similarly supported. Our results thus indicate that alexithymia is relatively stable trait that can be robustly measured by the PAQ.
Concurrent validity was also supported. The PAQ subscales were significantly and highly positively correlated with another established measure of alexithymia (TAS-20), as well as significantly associated with markers of stress, anxiety and depressive symptoms. Moreover, the PAQ subscales showed empirically good discriminant validity against the general psychological distress factor. These results are also consistent with other validation studies on the PAQ provided in different cultures (15, 18).
In terms of the importance of emotional valence, participants generally reported significantly more difficulties appraising their negative emotions compared to their positive emotions. Thus, our results are consistent with previous reports noting the utility of accounting for valence when assessing alexithymia (14, 18). As for age and gender differences, our results suggest that younger people have significantly higher levels of alexithymia, and females score higher in the N-DIF and N-DDF subscales, i.e., they have more difficulties appraising negative emotions than males. Given these differences, we provided group norms for the all PAQ subscales and composite scores for females and males in two age groups from the general population of Poland. In future work, these norms may be helpful when comparing alexithymia levels across individuals from the general community and clinical samples.
Limitations and strengths of the study
The validation study took place in a broad general sample with a wide range of ages, but we did not test the PAQ in clinical or adolescent samples. As such, future work will be needed to test the generalisability of our findings. That said, our study lends further support to the cross-cultural validity of the PAQ, largely mirroring the results of past studies conducted in other languages (14–16, 18). This reflects the strengths of the Polish version of the PAQ and presents a good support for conducting the studies on clinical and adolescent samples. The Polish version of the PAQ appears to be useful tool for comprehensively measuring the multidimensional alexithymia construct.
Data availability statement
The raw data supporting the conclusions of this article will be made available by the authors, without undue reservation.
Ethics statement
The studies involving human participants were reviewed and approved by the Kazimierz Wielki University Research Ethics Committee. The patients/participants provided their written informed consent to participate in this study.
Author contributions
PL: conceptualization, formal analysis, data curation, investigation, methodology, writing, reviewing and editing, supervision, and project administration. DP: writing, reviewing, and editing as well as supervision. KM-G: data curation, investigation, and methodology. All authors approved the final article and agreed to the authorship order.
Funding
This work was supported by the Kazimierz Wielki University (Bydgoszcz, Poland).
Acknowledgments
The authors are grateful to Prof. Elżbieta Kasprzak (Faculty of Psychology, Kazimierz Wielki University) for financial support for publication. The authors would also like to thank the colleagues for their suggestions in translation procedure and the participants of this study for their effort.
Conflict of interest
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
Supplementary material
The Supplementary Material for this article can be found online at: https://www.frontiersin.org/articles/10.3389/fpsyt.2022.1047191/full#supplementary-material
References
1. Nemiah JC, Sifneos PE. Psychosomatic illness: A problem in communication. Psychother Psychosom. (1970) 18:154–60. doi: 10.1159/000286074
2. Preece DA, Becerra R, Robinson K, Allan A, Boyes M, Chen W, et al. What is alexithymia? Using factor analysis to establish its latent structure and relationship with fantasizing and emotional reactivity. J Pers. (2020) 88:1162–76. doi: 10.1111/jopy.12563
3. Sifneos PE. The prevalence of “alexithymic” characteristics in psychosomatic patients. Psychother Psychosom. (1973) 22:255–62. doi: 10.1159/000286529
4. Preece DA, Mehta A, Becerra R, Chen W, Allan A, Robinson K, et al. Why is alexithymia a risk factor for affective disorder symptoms? The role of emotion regulation. J Affect Disord. (2022) 296:337–41. doi: 10.1016/j.jad.2021.09.085
5. Fava GA, Cosci F, Sonino N. Current psychosomatic practice. Psychother Psychosom. (2017) 86:13–30. doi: 10.1159/000448856
6. Leweke F, Bausch S, Leichsenring F, Walter B, Stingl M. Alexithymia as a predictor of outcome of psychodynamically oriented inpatient treatment. Psychother Res. (2009) 19:323–31. doi: 10.1080/10503300902870554
7. Preece D, Becerra R, Allan A, Robinson K, Dandy J. Establishing the theoretical components of alexithymia via factor analysis: Introduction and validation of the attention-appraisal model of alexithymia. Pers Individ Differ. (2017) 119:341–52. doi: 10.1016/j.paid.2017.08.003
8. Bagby RM, Taylor GJ, Parker JD. The Twenty-item Toronto Alexithymia Scale—II. Convergent, discriminant, and concurrent validity. J Psychosom Res. (1994) 38:33–40. doi: 10.1016/0022-3999(94)90006-X
9. Bagby RM, Taylor GJ, Quilty LC, Parker JD. Reexamining the factor structure of the 20-item Toronto alexithymia scale: commentary on Gignac, Palmer, and Stough. J Pers Assess. (2007) 89:258–64. doi: 10.1080/00223890701629771
10. Kooiman CG, Spinhoven P, Trijsburg RW. The assessment of alexithymia: a critical review of the literature and a psychometric study of the Toronto Alexithymia Scale-20. J Psychosom Res. (2002) 53:1083–90. doi: 10.1016/S0022-3999(02)00348-3
11. Leweke F, Leichsenring F, Kruse J, Hermes S. Is alexithymia associated with specific mental disorders? Psychopathology. (2012) 45:22–8. doi: 10.1159/000325170
12. Becerra R, Preece D, Campitelli G, Scott-Pillow G. The assessment of emotional reactivity across negative and positive emotions: Development and validation of the perth emotional reactivity scale (PERS). Assessment. (2019) 26:867–79. doi: 10.1177/1073191117694455
13. Greene D, Hasking P, Boyes M, Preece D. Measurement invariance of two measures of alexithymia in students who do and who do not engage in non-suicidal self-injury and risky drinking. J Psychopathol Behav Assess. (2020) 42:808–25. doi: 10.1007/s10862-020-09806-7
14. Preece D, Becerra R, Robinson K, Dandy J, Allan A. The psychometric assessment of alexithymia: Development and validation of the Perth Alexithymia Questionnaire. Pers Individ Differ. (2018) 132:32–44. doi: 10.1016/j.paid.2018.05.011
15. Bilge Y, Bilge Y. The measurement of Attention-Appraisal Model of Alexithymia: psychometric properties of the Perth Alexithymia Questionnaire in Turkish. Anatolian J Psychiat. (2020) 21:71. doi: 10.5455/apd.133183
16. Mousavi Asl E, Mahaki B, Khanjani S, Mohammadian Y. The assessment of alexithymia across positive and negative emotions: the psychometric properties of the iranian version of the perth alexithymia questionnaire. Iran J Psychiatry Behav Sci. (2020) 14:102317. doi: 10.5812/ijpbs.102317
17. Lashkari A, Dehghani M, Sadeghi-Firoozabadi V, Heidari M, Khatibi A. Further Support for the Psychometric Properties of the Farsi Version of Perth Alexithymia Questionnaire. Front Psychol. (2021) 12:657660. doi: 10.3389/fpsyg.2021.657660
18. Becerra R, Baeza CG, Fernandez AM, Preece DA. Assessing alexithymia: psychometric properties of the perth alexithymia questionnaire in a spanish-speaking sample. Front Psychiatry. (2021) 12:710398. doi: 10.3389/fpsyt.2021.710398
19. Fynn DM, Preece DA, Gignac GE, Pestell CF, Allan A, Kraats CV, et al. Assessing alexithymia in adults with acquired brain injury: Psychometric properties of the Perth Alexithymia Questionnaire. J Affect Disord. (2022) 302:224–33. doi: 10.1016/j.jad.2022.01.091
20. Chan J, Becerra R, Weinborn M, Preece D. Assessing alexithymia across Asian and western cultures: psychometric properties of the perth alexithymia questionnaire and Toronto alexithymia scale-20 in Singaporean and Australian samples. J Pers Assess. (2022) 1–17. doi: 10.1080/00223891.2022.2095641
21. Preece DA, Becerra R, Allan A, Robinson K, Chen W, Hasking P, et al. Assessing alexithymia: Psychometric properties of the Perth Alexithymia Questionnaire and 20-item Toronto Alexithymia Scale in United States adults. Pers Individ Differ. (2020) 166:110138. doi: 10.1016/j.paid.2020.110138
22. Veirman E, Van Ryckeghem D, Verleysen G, De Paepe AL, Crombez G. What do alexithymia items measure? A discriminant content validity study of the Toronto-alexithymia-scale-20. PeerJ. (2021) 9:11639. doi: 10.7717/peerj.11639
23. Leising D, Grande T, Faber R. The Toronto Alexithymia Scale (TAS-20): A measure of general psychological distress. J Res Pers. (2009) 43:707–10. doi: 10.1016/j.jrp.2009.03.009
24. Preece DA, Becerra R, Boyes ME, Northcott C, McGillivray L, Hasking PA. Do self-report measures of alexithymia measure alexithymia or general psychological distress? A factor analytic examination across five samples. Pers Individ Differ. (2020) 155:109721. doi: 10.1016/j.paid.2019.109721
25. Mattila AK, Salminen JK, Nummi T, Joukamaa M. Age is strongly associated with alexithymia in the general population. J Psychosom Res. (2006) 61:629–35. doi: 10.1016/j.jpsychores.2006.04.013
26. Scigała DK, Zdankiewicz-Scigała E, Bedyńska S, Kokoszka A. Psychometric properties and configural invariance of the polish - language version of the 20-item Toronto alexithymia scale in non-clinical and alcohol addict persons. Front Psychol. (2020) 11:1241. doi: 10.3389/fpsyg.2020.01241
27. Kroenke K, Spitzer RL, Williams JB, Löwe B. An ultra-brief screening scale for anxiety and depression: the PHQ-4. Psychosomatics. (2009) 50:613–21. doi: 10.1016/S0033-3182(09)70864-3
28. Larionow P, Mudło-Głagolska K. The Patient Health Questionnaire−4: the factor structure, invariance measurement, and the latent profile analysis of anxiety and depressive symptoms in a Polish general community sample. Research Square [Preprint]. (2022). doi: 10.21203/rs.3.rs-2050825/v1
29. Cohen S, Kamarck T, Mermelstein R. A global measure of perceived stress. J Health Soc Behav. (1983) 24:385–96. doi: 10.2307/2136404
30. Kleszczewska D, Mazur J, Dzielska A, Michalska A, Gaspar de Matos M, Santos T, et al. Improve the Youth. Zdrowie Psychiczne Młodziezy. Raport z badań. Warszaw: Instytut Matki i Dziecka (2018).
31. Mundfrom DJ, Shaw DG, Ke TL. Minimum sample size recommendations for conducting factor analyses. Int J Test. (2005) 5:159–68. doi: 10.1207/s15327574ijt0502_4
32. Hu LT, Bentler PM. Cutoff criteria for fit indexes in covariance structure analysis: conventional criteria versus new alternatives. Struct Equ Modeling. (1999) 6:1–55. doi: 10.1080/10705519909540118
33. Byrne BM. Structural Equation Modeling With AMOS: Basic Concepts, Applications, and Programming, 2nd eds. New York: Routledge. (2010).
34. Furlan L, Sterr A. The applicability of standard error of measurement and minimal detectable change to motor learning research—a behavioral study. Front Hum Neurosci. (2018) 12:95. doi: 10.3389/fnhum.2018.00095
35. Eatwell J. “Using norms in the interpretations of test results”. In: Practice issues for clinical and applied psychologists in New Zealand, eds. H. Love, W. Whittaker, Wellington: The New Zealand Psychological Society (1997). p. 268–276.
36. Kolenikov S, Bollen KA. Testing negative error variances. Sociol Methods Res. (2012) 41:124–67. doi: 10.1177/0049124112442138
Keywords: alexithymia, negative emotions, positive emotions, psychometric properties, psychopathology
Citation: Larionow P, Preece DA and Mudło-Głagolska K (2022) Assessing alexithymia across negative and positive emotions: Psychometric properties of the Polish version of the Perth Alexithymia Questionnaire. Front. Psychiatry 13:1047191. doi: 10.3389/fpsyt.2022.1047191
Received: 17 September 2022; Accepted: 15 November 2022;
Published: 30 November 2022.
Edited by:
Emanuel Jauk, Medical University of Graz, AustriaReviewed by:
Francesco Monaco, Azienda Sanitaria Locale Salerno, ItalyMohsen Khosravi, Zahedan University of Medical Sciences, Iran
Pasquale Scognamiglio, ASL Napoli 3 Sud, Italy
Copyright © 2022 Larionow, Preece and Mudło-Głagolska. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Paweł Larionow, cGF2ZWwmI3gwMDA0MDt1a3cuZWR1LnBs